Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805516 · ClinicalTrials.gov registry record · NA
Central Obesity and Cancer Prevention for Chinese American Women
A NA study, sponsored by San Francisco State University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03805516: Completed NA study, sponsored by San Francisco State University.
NCT03805516 is a NA study that has completed, run by San Francisco State University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03805516, a NA study, has completed, sponsored by San Francisco State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese American women in San Francisco. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical activity. Ultimately, the findings will advance the NIH mission of enhancing health promotion and disease prevention.
Primary Outcome
waist measured in centimeters by NIH waist circumference measurement protocol
Interventions
- BEHAVIORAL Control
- BEHAVIORAL SCOPP-CW
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-10-16 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT03805516 record still lists
NCT03805516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03805516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03805516 about?
NCT03805516 is a clinical study titled "Central Obesity and Cancer Prevention for Chinese American Women". This project examines the feasibility of a smartphone-based intervention to reduce obesity and breast cancer risk among Chinese American women in San Francisco. The proposed intervention is to use the mobile application and an activity tracker device to promote a healthier lifestyle and physical act...
What is the current status of trial NCT03805516?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-10-16. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT03805516?
The interventions under investigation include: Control (BEHAVIORAL), SCOPP-CW (BEHAVIORAL).
Who is sponsoring clinical trial NCT03805516?
This trial is sponsored by San Francisco State University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03805516's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI